US Senate appropriators direct the Food and Drug Administration to establish an enforcement discretion policy for products containing hemp-derived cannabidiol, but omit a step their House counterparts request of first setting a safe level for the ingredient's use in food and dietary supplements.
The instruction stated in the Senate
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?